IRAP en es it fr

IRAP Brand names, IRAP Analogs

IRAP Brand Names Mixture

  • No information avaliable

IRAP Chemical_Formula


IRAP RX_link

IRAP fda sheet

IRAP msds (material safety sheet)

IRAP Synthesis Reference

No information avaliable

IRAP Molecular Weight


IRAP Melting Point

No information avaliable

IRAP H2O Solubility

No information avaliable

IRAP State




IRAP Dosage Forms


IRAP Indication

For treatment of adult rheumatoid arthritis

IRAP Pharmacology

Used to treat rheumatoid arthritis, Kineret blocks the biologic activity of IL-1 by competitively inhibiting IL-1 binding to the interleukin-1 type I receptor (IL-1RI), which is expressed in a wide variety of tissues and organs.1 IL-1 production is induced in response to inflammatory stimuli and mediates various physiologic responses including inflammatory and immunological responses. Patients with rheumatoid arthritis have elevated levels of IL-1. The levels of the naturally occurring IL-1Ra in synovium and synovial fluid from rheumatoid arthritis (RA) patients are not sufficient to compete with the elevated amount of locally produced IL-1. Increasing the levels of IL-1Ra by artificial means reduces the negative effects (cartilage degradation, bone resorption) of IL-1.

IRAP Absorption

No information avaliable

IRAP side effects and Toxicity

No information avaliable

IRAP Patient Information


IRAP Organisms Affected

Humans and other mammals